No radiotherapy an option for older breast cancer patients, study shows
Radiotherapy does not improve survival rates in older patients with early breast cancer, new research suggests.
Feb 15, 2023
0
22
Radiotherapy does not improve survival rates in older patients with early breast cancer, new research suggests.
Feb 15, 2023
0
22
An unexpected discovery made by experts at the Brain Tumor Center at Cincinnati Children's while studying a rare-but-deadly type of brain tumor may also lead to improved treatments for several other forms of cancer that share ...
Feb 2, 2023
0
15
Results from the SWOG S1416 clinical trial show that adding veliparib to chemotherapy can significantly extend progression-free survival (PFS) times in patients with triple-negative breast cancer (TNBC) that has a "BRCA-like" ...
Jan 31, 2023
0
34
First-line regimens with endocrine therapy (ET) may be associated with benefits among patients with human epidermal growth factor receptor 2-positive (ERBB2-positive [formerly HER2-positive]) metastatic breast cancer (MBC), ...
Dec 20, 2022
0
0
The use of circulating tumor cell (CTC) count to guide the choice between chemotherapy and endocrine therapy as first-line therapy for patients with metastatic, estrogen receptor (ER)-positive/HER2-negative breast cancer ...
Dec 8, 2022
0
2
Radiotherapy after breast-conserving surgery in conjunction with chemotherapy or tamoxifen to treat early breast cancer reduces the risk of the disease returning in the same breast in the next ten years, but makes little ...
Nov 17, 2022
0
3
New research from University of Alabama at Birmingham researchers is shedding light on racial disparities in breast cancer mortality in women who live in economically deprived neighborhoods.
Nov 8, 2022
0
57
Patients who received trastuzumab deruxtecan (T-DXd) for human epidermal growth factor receptor 2 (HER2)-low metastatic breast cancer reported that the treatment maintained their quality of life (QoL) compared to conventional ...
Sep 12, 2022
0
9
The environment in which breast cancer arises—the interplay between the patient's BMI, tumor size and cancer-specific proteins—is of importance for the prognosis. This is shown in a study from Lund University in Sweden. ...
Aug 25, 2022
0
4
A new study led by University of Ottawa professors has found Canadian provinces that annually screen women aged 40–49 had lower proportions of advanced breast cancer compared to women aged 50–59 from provinces that did ...
Aug 12, 2022
0
43